Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Edwards Insider Profile
4 Followers
Martin Edwards, Director at CoLucid Pharmaceuticals, holds 0.00 shares in CoLucid Pharmaceuticals (Ticker: CLCD), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV), holds ― shares in Inozyme Pharma (Ticker: INZY). Most recently, Martin Edwards ― shares of CoLucid Pharmaceuticals on ― for an estimated value of ―.
Martin Edwards CoLucid Pharmaceuticals (CLCD)Director
CoLucid Pharmaceuticals (CLCD)
Director
Ranked #39,095 out of 98,743 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Martin Edwards holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Edwards
Martin Edwards's Trading History
CoLucid Pharmaceuticals
―
―
―
$0.00
KalVista Pharmaceuticals
―
Director
―
―
Inozyme Pharma
―
Director
―
―
Reata Pharmaceuticals
Sep 26, 2023
―
Uninformative Sell
―
$0.00
Verona Pharma
Nov 22, 2023
Director
Informative Buy
61.74K
$2.15M
Morphic Holding
Nov 15, 2023
Director
Informative Buy
48.80K
$69.69K
List of latest transactions for each holding click on a transaction to see Martin Edwards's performance on stock
You May Also Like
Martin Edwards insider profile FAQ
What is the percentage of profitable transactions made by Martin Edwards?
The percentage of profitable transactions made by Martin Edwards is 100%.
What is the average return per transaction made by Martin Edwards?
The average return per transaction made by Martin Edwards is 20.00%.
What stocks does Martin Edwards hold?
Martin Edwards holds: CLCD, KALV, INZY, RETA, VRNA, MORF stocks.
What was Martin Edwards’s latest transaction?
Martin Edwards latest transaction was an Uninformative Buy of ―.
What was Martin Edwards's most profitable transaction?
Martin Edwards’s most profitable transaction was an Informative Buy of MORF stock on November 15, 2023. The return on the trade was 28.40%.
What is Martin Edwards's role in CoLucid Pharmaceuticals?
Martin Edwards's role in CoLucid Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.